Fortis Therapeutics
Latest round
- Series A
Last raised
- Mar 2021
Total raised
- $58M
Investors
- 7
About Fortis Therapeutics
Fortis Therapeutics, Inc.Founded in 2016 and headquartered in the US, Fortis Therapeutics, Inc. is dedicated to advancing proprietary therapeutics targeting CD46 proteins.Fortis Therapeutics specializes in the development of proprietary precision therapies targeting CD46 proteins, focusing on transforming cancer treatment outcomes. Their core offerings include novel anti-CD46 therapeutics specifically designed to treat late-stage prostate cancer and multiple myeloma. These therapies utilize advanced technology to precisely direct treatment to cancerous cells while minimizing damage to healthy tissues, thereby improving patient quality of life and treatment efficacy. The company aims to serve a diverse client base, including healthcare providers, hospitals, and research institutions, primarily within the United States and regions with advanced healthcare infrastructure such as Europe and Asia. Revenue generation is anticipated through strategic partnerships, licensing agreements, and collaborations with pharmaceutical companies and healthcare institutions interested in their innovative products. The company’s business model is structured around B2B transactions, where healthcare providers and research institutions acquire the therapeutics for clinical use and trials. These transactions may include frameworks for milestone payments and royalties based on the commercial success of their therapies.In March 2021, Fortis Therapeutics, Inc. The company plans to expand its product offerings by developing additional therapies targeting various cancers and aims to penetrate new markets in Europe and Asia by 2023.
Who invested in Fortis Therapeutics
7 investors across 2 rounds
See all investors in Fortis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Fortis Therapeutics
Who invested in Fortis Therapeutics?
Fortis Therapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Fortis Therapeutics raised?
Fortis Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Fortis Therapeutics last raise money?
Fortis Therapeutics's most recent round on record is a Series A, in Mar 2021.
What does Fortis Therapeutics do?
Fortis Therapeutics is a biotechnology company.
Where is Fortis Therapeutics headquartered?
Fortis Therapeutics is headquartered in US.
Which VCs invest in companies like Fortis Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Fortis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Fortis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.